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Abstract
Primate lentivirus (HIV and SIV) vpr accessory genes encode 12- to 14-kDa proteins which induce cell cycle arrest at the G2 phase of
infected cells, preventing them from going through mitosis. Members of the HIV-2/SIVmac/SIVsmm group also encode a second closely
related accessory protein called Vpx. Vpx and HIV Vpr are critical for virus replication in nondividing cells due to their participation in
nuclear import of the preintegration complex. Caprine arthritis encephalitis virus (CAEV) and maedi visna virus are the natural lentiviruses
of domestic goat and sheep, respectively, and their genomes do not carry vpr and vpx genes. In this study, we generated chimeric
CAEV-based genomes carrying vpr and vpx genes from SIVmac239 and tested their ability to induce G2 cell cycle arrest in infected caprine
cells. CAEV–pBSCAvpxvpr is the chimeric genome that was shown to be infectious and replication competent. Our data demonstrated that
CAEV–pBSCAvpxvpr-infected goat synovial membrane cell monolayer developed more cytopathic effects and a high proportion of cells
remained in the G2 phase of cell cycle. This G2 arrest was observed both at the early and at the late stages of infection, while minimal effect
was observed with the parental CAEV–pBSCA. These results, described for the first time in mammalian cells other than those of primates,
indicate that Vpr-induced G2 cell cycle arrest is not restricted to only primate cells. Thus, conservation of Vpx/Vpr protein functions in
caprine cells suggests a possible role for these proteins in the virus life cycle and its ability to adapt to new hosts. The data presented here
thus raise a pertinent question about the biological significance of the conservation of Vpr and Vpx functions in caprine cells despite the
high phylogenic distance between primates and small ruminants.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Lentiviruses are nononcogenic small enveloped RNA
viruses, which are grouped in a genus of the Retrovirus
family and known to infect primarily the cells of immune
system. They cause persistent infection and chronic degen-
erative disease in their hosts (Haase, 1986). Members of this
subfamily include the human immunodeficiency virus
(HIV) type 1 and 2, simian immunodeficiency virus (SIV),
feline immunodeficiency virus (FIV), bovine immunodefi-
ciency virus (BIV) or the lethal Jembrana disease virus
(JDV), equine infectious anemia virus (EIAV), and the
prototypic maedi visna virus (MVV) and caprine arthritis
encephalitis virus (CAEV).
CAEV is the natural lentivirus that has been isolated
from goats (Crawford et al., 1980; Narayan et al., 1980) and
found to be closely related to the primate HIV-1, HIV-2,
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and SIV lentiviruses. CAEV causes chronic inflammatory
and degenerative disease mainly in joints and mammary
glands and occasionally in the lung and central nervous
system of infected goats. In contrast to HIV and SIV, CAEV
does not induce immunodeficiency in infected goats; this
property correlates with its inability to cause productive
infection of CD4 T lymphocytes (Gorrell et al., 1992) and
to have a preferential tropism for the monocyte/macrophage
cell lineage (Narayan et al., 1982, 1983). One of the features
that distinguishes primate from small ruminant lentiviruses
(CAEV) is their genome complexity. Indeed, the primate
HIV-1, HIV-2, and SIV lentivirus genomes encode for six
supplementary proteins in addition to the structural and
enzymatic proteins encoded by gag, pol, and env reading
frames common to all retroviruses (Trono, 1998), while
only three supplementary proteins were found to be ex-
pressed in small ruminant CAEV and MVV lentivirus ge-
nomes. Some primate lentivirus auxiliary genes are highly
conserved and perform important but less well understood
functions in vivo that contribute to their induced pathogen-
esis.
Vpr and vpx are closely related accessory genes which
derive from each other by duplication. All primate lentivirus
genomes express at least one of these gene products which
are efficiently incorporated into viral particles in a equimo-
lar amount of gag protein (Cohen et al., 1990b; Yuan et al.,
1990; Subbramanian and Cohen, 1994). The genomes of
HIV-1, SIVcpz, SIVmnd, and SIVsyk contain the vpr gene
only, whereas those of HIV-2, SIVsmm, and SIVmac con-
tain both vpr and vpx. The only lentivirus genome that has
been first found to encode for Vpx only is that of the
SIVagm (Guyader et al., 1987; Fukasawa et al., 1988). This
gene was later reidentified as vpr coding sequences (Tristem
et al., 1990).
HIV-1 Vpr is a 14-kDa, 96-amino-acid protein expressed
primarily from a singly spliced rev-dependent mRNA (Co-
hen et al., 1990a; Arrigo and Chen, 1991) and is conserved
among the primate lentiviruses HIV-1, HIV-2, and SIV
(Stivahtis et al., 1997). In the cell culture system, Vpr was
found to be implicated in two main functions. It promotes
the cytoplasm to nucleus import of the preintegration com-
plex and facilitates its passage across the nuclear pore in
newly infected cells. This process helps HIV-1 to cause
productive infection in nondividing cells (Heinzinger et al.,
1994). The second biological and important activity of
HIV-1 Vpr is the G2 cell cycle arrest in infected and
proliferating human T cells (Jowett et al., 1995; Bartz et al.,
1996; Bukrinsky and Adzhubei, 1999). HIV-2 and SIV Vpr
were shown to induce cell cycle arrest in transfected human
cells, although the effect was less pronounced than with
HIV-1 Vpr in both human and simian cells (Di Marzio et al.,
1995; Planelles et al., 1996). This cell cycle arrest was also
observed in the fission yeast Schizosaccharomyces pombe
over expressing HIV-1 vpr (Zhao et al., 1996; Zhang et al.,
1997). In contrast, HIV-1 Vpr gene product was found to
prevent NIH 3T3 cells from proliferation but in the absence
of G2 arrest of the cell cycle (Nishino et al., 1997). In
addition, HIV-1 was shown to replicate poorly in mouse and
rat cells that have been previously engineered to support
HIV-1 infection by expressing constitutively both the re-
ceptor and the coreceptor of this virus, but, curiously, the
hamster cell line CHO was found to replicate HIV-1 more
efficiently (Bieniasz and Cullen, 2000; Keppler et al., 2001,
2002). The G2 arrest of the cell cycle was found to be
associated with the inhibition of activation of the p34cdc2–
cyclin B complex by increasing its phosphorylation at spe-
cific sites both in fission yeast and in human cells (He et al.,
1995; Re et al., 1995; Mahalingam et al., 1997). In addition,
the G2 arrest mediated by HIV-1 Vpr was shown to be
associated with an enhancement of the transcriptional ac-
tivity of the HIV-1 long terminal repeat, leading to efficient
virus production (Goh et al., 1998). Recent data demon-
strated that the incorporated amount of Vpr into HIV-1 viral
particles is sufficient to induce G2 arrest prior to the de novo
synthesis of proviral expressed proteins. These data suggest
that both infectious and noninfectious viruses are implicated
in the induction of HIV-1 pathogenesis (Poon et al., 1998;
Bachand et al., 1999);
Vpx is a 18-kDa, 112-amino-acid protein which is highly
conserved among divergent isolates of the human HIV-2
and monkey SIVs. It is well accepted now that vpr and vpx
genes derive from each other by duplication (Tristem et al.,
1990, 1992), or vpx arose through the acquisition of vpr
gene from SIVagm (Sharp et al., 1996). Despite their high
similarity in size and amino-acid sequence composition,
recent reports demonstrate that SIVsmm Vpr and Vpx pro-
teins have distinct and not complementary functions
(Fletcher et al., 1996). SIV Vpr induces the G2 cell cycle
arrest, whereas Vpx is involved in the nuclear import of
viral preintegration complex (Fletcher et al., 1996; Pancio et
al., 2000a, 2000b). Indeed, HIV-2 and SIVmac Vpx proteins
were shown to have no detectable influence on the cell cycle
progression in CV-1 monkey or HeLa and 293 human cells
(Di Marzio et al., 1995; Planelles et al., 1996).
Our aim in this study was to develop an original lenti-
virus model to study the functions of SIVmac Vpr and Vpx
proteins in infected goat cells. Because of its simpler ge-
nome organization, CAEV was an appropriate system
to develop tools for this study. The infectious molecular
clone of CAEV genome (CAEV–pBSCA) was used to de-
rive a chimeric genome in which the SIVmac vpr and vpx
accessory genes were inserted. This genome, named CAEV–
pBSCAvpxvpr, was shown to be replication competent and
to produce virus titers equivalent or higher than those ob-
tained with the parental CAEV–pBSCA. Interestingly,
CAEV–pBSCAvpxvpr chimeric virus was shown to be as-
sociated with increased cytopathic effect induction in the
infected cell monolayers. On the other hand, SIV Vpr and
Vpx were found to induce G2 arrest of the cell cycle of
infected goat cells. Our data also suggest that virion-im-
ported Vpr/Vpx of SIVmac is sufficient to induce the cell
cycle arrest at the early stage of infection. These data were
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confirmed by the inhibition of reverse transcription using
AZT in CAEV–pBSCAvpxvpr-infected cells which did not
abolish the G2 arrest induced by SIV Vpr/Vpx proteins. To
date, our chimeric virus system is a unique lentivirus model
that has been developed to study the functions of primate
lentivirus accessory genes in the context of a lentivirus
infection. Interestingly, with the exception of primate cells,
this is the only mammalian cell system in which SIV Vpr
and Vpx were shown to induce specific effects following
lentivirus infection. The yeast studies were done by trans-
fection with expression plasmids.
Results
Construction of CAEV genome containing SIV vpx and
vpr genes
Recently we reported the isolation of a full-length infectious
molecularly cloned genome (derived from the CO strain of
CAEV) that we used to derive CAEV–pBSCA (Mselli-Lakhal
et al., 2000). The coding sequences of Vpx and Vpr proteins
from SIVmac239 were inserted into the unique SmaI site at the
end of tat coding sequences and the beginning of the spacer
sequence located upstream of the env gene of CAEV–pBSCA
(Fig. 1). The resulting recombinant genome that contained the
inserted vpx and vpr genes in the same transcription orientation
as the virus was named CAEV–pBSCAvpxvpr.
CAEV–pBSCAvpxvpr chimeric virus is replication
competent
To determine whether the virus derived from the CAEV–
pBSCAvpxvpr chimeric genome is replication competent, we
transfected goat synovial membrane (GSM) cells with CAEV–
pBSCAvpxvpr plasmid DNA. Transfection of GSM cells with
CAEV–pBSCA served as a control. Various dilutions of cul-
ture supernatants collected at day 7 posttransfection were used
to inoculate fresh GSM cells and virus was titrated according
to the Reed Muench method. Virus stocks in the culture me-
dium harvested at day 7 posttransfection were found to contain
titers equivalent to 106 and 107 TCID50/ml for CAEV–pB-
SCAvpxvpr chimerical virus. Virus titers obtained with the
Fig. 1. Genome organization of CAEV–pBSCAvpxvpr chimera. To produce CAEV–pBSCAvpxvpr chimeric genome, vpx and vpr genes were isolated from
SIVmac 239 genome by PCR amplification (top). The PCR product was inserted in the unique SmaI site located at the 3 end of tat gene upstream of the
spacer sequences located between tat and env genes of CAEV–pBSCA (middle) plasmid which carry the complete genome of the infectious CAEV. The
resulting recombinant genome that contains SIV vpr and vpx genes in the same transcriptional orientation than CAEV was named CAEV–pBSCAvpxvpr
(bottom). PCR products amplified with the various primer sets are indicated under the maps.
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culture medium harvested at day 7 posttransfection with the
parental CAEV–pBSCA were similar or slightly lower (105–
106 TCID50/ml). These results demonstrated that despite a
10% increase in the size of genome, CAEV–pBSCAvpxvpr is
fully replication competent.
SIV Vpr/Vpx proteins are highly expressed in infected
caprine cells
GSM infected with CAEV–pBSCAvpxvpr were tested for
the expression of SIV Vpx and Vpr proteins using the immu-
nocytochemistry and radioimmunoprecipitation methods. Im-
munostaining with a polyclonal antibody directed against SIV
Vpx and Vpr proteins revealed a high expression of SIV Vpx
and Vpr proteins in only cells infected with the chimerical
virus CAEV–pBSCAvpxvpr, tested at 5 days postinfection
(Fig. 2c). No specific immunostaining was detected either in
the noninfected GSM cells or in the CAEV–pBSCA-infected
GSM cells (Fig. 2a and b). The immunocytochemestry data
were confirmed by radioimmunoprecipitation that revealed a
14-kDa band, specifically precipitated with the SIV Vpr and
Vpx specific polyclonal antibody only in the cell lysate of
GSM cells infected with CAEV–pBSCAvpxvpr and corre-
sponding to Vpx and Vpr proteins (Fig. 3b). CAEV–pBSCA
Fig. 2. Immunocytochemistry detection of SIV Vpx and Vpr expression. Goat synovial membrane (GSM) cells infected with CAEV–pBSCAvpxvpr were
used to detect Vpr and Vpx from SIV by immunocytochemistry using a specific mouse anti-Vpx and Vpr polyclonal serum. Noninfected GSM cells were
used as negative control (a); CAEV–pBSCA-infected GSM cells (b); CAEV–pBSCAvpxvpr-infected GSM cells showing strong staining in most of the cells
(c). Original magnification  400.
Fig. 5. Increased CPE in GSM cells expressing SIV Vpx and Vpr proteins. GSM cells were infected with CAEV–pBSCA (b) and pBSCAvpxvpr (c)
at a multiplicity of infection of 0.1. Noninfected cells were used as a negative control (a). At 7 days postinfection cells were stained with May–
Gru¨nwald Giemsa and examined for the presence of cytopathic effect (giant multinucleated cells, black arrows). To quantify the CPE induction, the num-
bers of nuclei per syncytium in GSM cell monolayers were counted in 20 randomly selected syncitia (d) and the number of syncitia per field of vision
in 10 randomly selected fields (e) for CAEV–pBSCA and CAEV–pBSCAvpxvpr and used to determine the average values that were use to plot the graphs
(d and e).
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viral proteins were immunoprecipitated with our hyperimmune
goat polyclonal serum G9615 both from the supernatant and
from the cell lysate of infected cells (Fig. 3a). Taken together,
the data from radioimmunoprecipitation and immunocyto-
chemistry analysis showed an efficient expression of SIV Vpx
and Vpr proteins in goat cells.
SIV vpr and vpx genes are not stably inserted in CAEV–
pBSCAvpxvpr chimerical genome
To determine whether the SIV vpx and vpr genes were
stably inserted in CAEV–pBSCA genome, we serially pas-
saged the CAEV–pBSCAvpxvpr virus in GSM cells and
analyzed the presence of vpr and vpx genes in the virus
genome by PCR in DNA of infected cells. All tested sam-
ples from the various passages revealed positive PCR sig-
nals. PCR amplification using oligonucleotide primers spe-
cific to vpx and vpr genes resulted in a specific 734 bp PCR
product. We have presented PCR products obtained from
the first, fifth, and eighth passages of CAEV–pBSCAvpxvpr
(Fig. 4; lanes 4, 5, and 6). Similarly, with the oligonucleo-
tide primers specific to tat and env genes, a 876-bp PCR
product was detected with DNA from cells infected with the
passaged CAEV–pBSCAvpxvpr (Fig. 4; lanes 1, 2, and 3),
and a 142-bp PCR product was obtained with DNA from
cells infected with the passaged CAEV–pBSCA (Fig. 4;
lanes 7, 8, and 9). A similar 142-bp band was also detected
in concomitance with the 876-bp band in samples from the
passaged CAEV–pBSCAvpxvpr (Fig. 4; lanes 2 and 3).
These results indicate that CAEV genome loses the SIV vpx
and vpr sequences following the serial virus passages.
To correlate this instability of SIV vpx and vpr genes in
passaged CAEV–pBSCAvpxvpr and the protein expression
of these genes, we performed the immunocytochemistry to
detect SIV Vpx and Vpr proteins in GSM cell monolayers
infected with CAEV–pBSCAvpxvpr viruses from passages
1, 5, and 8. Our results showed that SIV Vpr and Vpx
proteins were expressed in cells inoculated with all pas-
saged viruses, but the proportion of cells not expressing SIV
Vpx and Vpr increased with the passages (data not shown).
Altogether, PCR and immunocytochemistry data clearly
indicate that at least a proportion of CAEV–pBSCAvpxvpr
virus genomes maintained both the SIV vpx and vpr genes
and their expressions after eight serial virus passages.
SIV Vpx and Vpr proteins increase the cytopathic effect
induced by CAEV
It is well known that CAEV-adapted laboratory strains
efficiently replicate in the indicator goat synovial membrane
cells. Virus replication is associated with development of
Fig. 3. Radioimmunoprecipitation of virus-specific proteins from infected
GSM cells. Radioimmunoprecipitation analysis was performed at 5 days
postinfection of GSM cells. Proteins were radiolabeled overnight by the
addition of 100 Ci of [35S]-methionine/cysteine in the culture medium of
infected cells. Virus-specific proteins were immunoprecipitated from the
supernatant and cell lysate fractions using specific polyclonal antibodies.
Proteins were separated using SDS–PAGE (12.5%) and then visualized
using standard autoradiography technique. (A) Immunoprecipitation from
supernatant (Sn) and cell lysate (c) from noninfected (1) and from CAEV–
pBSCA-infected cells (2) using the hyperimmune serum (G9615). (B)
Immunoprecipitation from uninfected (1) and CAEV–pBSCAvpxvpr (2)
infected cells with a polyclonal rabbit anti-Vpx serum. Positions of bands
of molecular mass (in kilodaltons) of prestained marker are shown on the
left. The 14-kDa SIV Vpx and Vpr proteins, the p25 major gag protein, and
the gp135 envelope glycoprotein of CAEV are indicated to the right of
each gel.
Fig. 4. PCR detection of vpx and vpr genes in DNA from GSM cells infected with passaged CAEV–pBSCAvpxvpr virus. DNAs isolated from cells infected
with CAEV–pBSCA and CAEV–pBSCAvpxvpr at passages 1, 5, and 8 were harvested at day 7 after infection of GSM cells. Oligonucleotide primers and
PCR conditions are described under Materials and Methods. PCR products were separated in 1.5% agarose gel and bands were visualized following ethidium
bromide staining. DNA from GSM cells infected with passage 1 (lane 1), passage 5 (lane 2), and passage 8 (lane 3) of CAEV–pBSCAvpxvpr were used with
oligonucleotide primers in tat and env genes to amplify a 876-bp fragment. These primers amplify a 142-bp PCR product from cells infected with
CAEV–pBSCA passage 1 (lane 7), passage 5 (lane 8), and passage 8 (lane 9). Oligonucleotide primers complementary to vpx and vpr genes amplified a
734-bp product from GSM cells infected with pBSCAvpxvpr from passage 1 (lane 4), passage 5 (lane 5), and passage 8 (lane 6). Lysate from uninfected
cells (NC) was used with CAEV tat/env and vpr/vpx specific oligonucleotide primers as negative controls.
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cytopathic effect (CPE) that is characterized by syncytium
formation (giant multinucleated cells) (Narayan et al., 1980;
Yaniv et al., 1985; Chebloune et al., 1996b; Singh et al.,
1999). To test whether SIV Vpx and Vpr proteins modify
the CPE induced by CAEV, GSM cells were inoculated in
parallel with CAEV–pBSCA and CAEV–pBSCAvpxvpr at
an MOI of 0.1, and at 5 days postinfection cells were stained
with May–Gru¨nwald Giemsa and then examined for the
presence of syncytial cytopathic effect. Unlike the parental
CAEV–pBSCA that causes mild and progressive fusion in
infected cell monolayers (Fig. 5b), CAEV–pBSCAvpxvpr
was found to be associated with an increased and rapid
cytopathic effect in infected monolayers (Fig. 5b and c). To
evaluate this difference in cytopathicity, we counted the
number of nuclei per syncitium for 20 randomly chosen
syncitia and the number of syncitia per field of vision in 10
randomly selected fields. The results were used to determine
the average values and to plot diagrams (Fig. 5d and e).
These results clearly show a significant increase of cyto-
pathicity of CAEV–pBSCAvpxvpr compared to that of the
parental CAEV–pBSCA.
G2 arrest of GSM cell cycle induced by SIV Vpx and Vpr
proteins
To determine whether GSM cells infected with CAEV–
pBSCAvpxvpr are arrested in the G2 phase of their cell
cycle, GSM cells were inoculated at an MOI of 1 with
CAEV–pBSCAvpxvpr and analyzed for their DNA content
by flow cytometry at 48 and 120 h after infection. Nonin-
fected and CAEV–pBSCA-infected GSM cells were used as
controls. Representative cell cycle profiles are shown in Fig.
6. For simplicity the results are represented as the ratio of
the percentage of cells in G2 relative to the percentage of
cells in G1 of the cell cycle.
Our result indicated that, as early as 48 and 120 h, SIV
Vpr and Vpx induced a specific G2 arrest in GSM cells
infected with CAEV–pBSCAvpxvpr compared to the non-
infected or CAEV–pBSCA-infected cells. At 48 h postin-
fection, the ratio of cells in G2 to cells in G1 was found to
be 0.09 and 0.06 for cells infected with CAEV–pBSCA and
noninfected cells, respectively (Fig. 6), while a higher ratio
(0.2) was observed in cells infected with CAEV–pBSCA-
vpxvpr. At 120 h postinfection a significant increase of the
rate of cells arrested in the G2 phase was observed only in
cells infected with CAEV–pBSCAvpxvpr since, compared
to the ratio obtained with the noninfected 0.06 and CAEV–
pBSCA-infected cells (0.08), cells infected with pBSCA-
vpxvpr showed a G2/G1 ratio of 0.35. This result is the first
demonstration that SIV Vpr and Vpx proteins are able to
induce a specific G2 arrest of the cell cycle in caprine cells.
The virion imported Vpr/Vpx proteins are sufficient to
induce G2 cell cycle arrest of caprine cell
Previous data with HIV-1 Vpr demonstrated that the
imported Vpr packaged in the virion was sufficient to in-
duce the G2 arrest prior to the de novo synthesis of viral
proteins from the proviral genome (Hrimech et al., 1999).
We were interested to determine whether this was similar in
caprine cells. To address this question, two steps were
performed. First, GSM cells were infected at a high multi-
plicity of infection (MOI5) and then analyzed by flow
cytometry for their DNA contents. As shown in Fig. 7, as
early as 18 h postinoculation a threefold increase of G2/G1
ratio was observed with GSM cells inoculated with CAEV–
pBSCAvpxvpr compared to the ratios obtained with cells
inoculated with CAEV–pBSCA or noninfected cells. Simi-
lar data were observed when the cells were examined 6 h
later (24 h postinfection). Second, to investigate whether the
observed early G2 arrest was due to the virion imported
Vpr/Vpx, reverse transcription of CAEVvpxvpr was inhib-
ited by AZT treatment of infected GSM cells as described
under Materials and Methods. The G2 arrest was analyzed
by flow cytometry for DNA content at 18, 24, and 48 h. As
shown in Fig. 8, AZT treatment did not result in abolition of
Fig. 6. G2 arrest of GSM cells expressing SIV Vpx and Vpr genes. GSM
cells were inoculated with CAEV–pBSCA and CAEV–pBSCAvprvpx at a
MOI of 1. Noninfected cells were used as negative control (NC). Cells
were harvested at 48 and 120 h postinfection and stained for DNA content
with propidium iodide. Cells were then analyzed by flow cytometry anal-
ysis using Lysis II analysis software over 10,000 events. The ratio of
percentage of cells in G2 to percentage of cells in G1 was used to plot the
graphs.
Fig. 7. Early G2 arrest of GSM cells expressing SIV vpr and vpx genes.
GSM cells were inoculated with CAEV–pBSCA and CAEV–pBSCAv-
prvpx at a MOI of 5. Noninfected cells were used as negative control (NC).
Eighteen and 24 h postinfection cells were stained with propidium iodide
for DNA content. DNA quantification was performed by flow cytometry
analysis using Lysis II analysis software. For simplicity, data shown are
reported as the ratio of the percentage of cells in G2 to the percentage of
cells in G1.
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early (18 h) induced G2 arrest in cells inoculated with
CAEV–pBSCA expressing SIV Vpr/Vpx. Indeed, the pro-
portion of cells arrested at the G2 phase was fourfold higher
in CAEV–pBSCAvpxvpr-infected cells (0.85%), compared
to the noninfected (0.28%) and CAEV–pBSCA-infected
cells (0.28%). Similar results were observed when AZT-
treated cells were analyzed at 24 and 48 h postinfection, but
the proportion of arrested cells was slightly lower. These
results suggest that the amount of SIV Vpr and Vpx pro-
teins imported in the particles during the inoculation of cells
was sufficient to induce an early G2 cell cycle arrest in
goat cells.
Discussion
The aim of this study was to determine whether the
introduction of primate lentivirus accessory genes into the
genome of CAEV results in any modification of the biolog-
ical properties of both the virus and the infected target cells.
Experiments presented in this study were designed to
generate a CAEV chimeric virus carrying in its genome
SIVmac vpr and vpx genes, to study their expression in
caprine cells. We examined whether the expression of Vpr
and Vpx proteins induces a G2 arrest of the cell cycle of
goat cells. Our full-length infectious CAEV–pBSCA ge-
nome (Mselli-Lakhal et al., 2000) was used to insert the
SIVmac239 vpx and vpr genes. The generated CAEV–
pBSCAvpxvpr recombinant plasmid DNA was used to pro-
duce CAEV–pBSCAvpxvpr virus stock that was used in
this study. Since the insertion of 734 bp resulted in almost
a 10% increase in the size of CAEV genome, our first
concern was to determine the stability of SIV genes in
CAEV genome. The data we presented here clearly show
that SIV vpx and vpr genes are conserved in the CAEV
genome at the early virus passages but deletion of these
genes was found to increase with subsequent virus passages.
Unlike CAEV tat coding sequences that were shown to be
dispensable for virus replication (Harmache et al., 1995)
and extremely conserved, the inserted SIV genes were not
very stable. Many speculations can be addressed to explain
this instability: (i) an active splicing event that removes the
inserted genes from the genomic RNA, (ii) an incompati-
bility of SIV DNA sequences into CAEV genomes that
requires mutation/adaptation events, (iii) the insertion posi-
tion between tat and env genes is critical for CAEV repli-
cation, (iv) the closely related sequences of vpr and vpx
genes induce recombination events that are not seen in the
SIV model.
Expression of SIV Vpr and Vpx in infected goat cells
resulted in an increased cytopathic effect in cell monolayers.
This result is in agreement with previous observations de-
scribing that SIV Vpr and Vpx induce changes of cell
morphology in both fission yeast S. pombe and human cells
(Zhao et al., 1996; Zhang et al., 1997). In fission yeast
model using HIV-1 Vpr, these changes were associated with
an increased cytopathic effect, biosynthesis of chitin in the
cell wall, disruption of the actin cytoskeleton, and altered
polarity for cell growth resulting in acute cell death (Zhao et
al, 1998). In our study we only observed an increased
cytopathic effect induced by the expression of SIV Vpr and
Vpx proteins. The induced cytopathic effect showed a
higher number of fused cells resulting in a higher number of
nuclei per syncitium and number of syncitia per field of
vision compared to noninfected and CAEV–pBSCA-in-
fected cells. This lack of induction of cell death in our
system compared to the fission yeast model could be due to
the difference of the level of HIV-1 Vpr and SIV Vpr and
Vpx expression in these two studied systems. Indeed, in
contrast to the fission yeast system in which Vpr is ex-
pressed by a plasmid vector introduced into target cells by
transfection, the CAEV model expresses SIV Vpr and Vpx
proteins in the context of virus infection with a very limited
copy number per cell. Our observations are also in agree-
ment with the data from previous studies in mammalian
cells in which Vpr-expressing cells remained viable in cul-
ture for at least 1 to 2 weeks before death (Levy et al., 1993;
Rogel et al., 1995). Furthermore, the cell death effect in-
duced by SIV Vpr and Vpx or HIV-2 Vpr and Vpx in fission
yeast S. pombe is milder than that observed with HIV-1 Vpr
(Zhao et al., 1996; Zhang et al., 1997).
In this study we found that SIV Vpr and Vpx mediate the
cell cycle arrest at the G2 phase similar to what was ob-
served in primate cells both at the early and at the late stage
of infection. Interestingly, the G2 arrest of cell cycle in goat
cells can be observed as early as 18 h postinoculation with
CAEV–pBSCAvpxvpr. In addition, this early G2 arrest was
shown to be independent of virus replication since the AZT
inhibition of reverse transcription of CAEV–pBSCAvpxvpr
did not abolish the G2 arrest of infected cells. These data
strongly suggest the implication of virion-imported SIV
Vpr/Vpx proteins inducing this early G2 arrest.
Previous studies have shown that SIVmac Vpr induces
Fig. 8. SIV Vpr and Vpx induce early G2 arrest of cell cycle in infected
goat cells in the absence of virus replication. GSM cell monolayers were
treated with 300 g/ml of AZT for 2 h and then inoculated in parallel with
CAEV–pBSCA and CAEV–pBSCAvprvpx at multiplicity of infection of
5. Noninfected cells were used as negative control (NC). Eighteen, 24, and
48 h postinfection cells were stained with propidium iodide for DNA
content. DNA quantification was performed by flow cytometry analysis
using Lysis II analysis software. For simplicity, data shown are reported as
the ratio of the percentage of cells in G2 to the percentage of cells in G1.
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less efficiently the G2 arrest both in human and in simian
cells compared to HIV-1 Vpr (Di Marzio et al., 1995;
Planelles et al., 1996). In goat cells we also found that
SIVmac Vpr and Vpx induce an attenuated G2 arrest com-
pared to the reported data with HIV-1 Vpr in primate cells.
However, the G2 arrest induced by SIV mac239 Vpr and
Vpx in goat cells is very similar to that reported for African
green monkey cells expressing Vpr from SIVagm or
SIVsmm (Stivahtis et al., 1997) and that in the human HeLa
cells or fibroblast cell lines derived from African green
monkey expressing the SIVmac Vpr (Planelles et al., 1996).
It was interesting to note that SIVmac Vpr and Vpx were
found to induce G2 arrest with the same efficiency in slow-
growing goat synovial membrane cells as was observed in
simian or human cell lines (Planelles et al., 1996).
Taken together these data clearly show the specific in-
teraction of SIVmac Vpr and Vpx with the cell components
from highly divergent species to induce G2 arrest. These
data also confirm the results from earlier reports and
strongly suggest that SIV Vpr-mediated cell cycle arrest is
not a species-restricted function. Other earlier studies re-
ported that G2 arrest function of Vpr is cell type specific and
depends on the primate species from which cells are de-
rived. Thus, SIVagm and SIVsyk Vpr proteins induced G2
arrest in African green monkey cells but were found to be
completely inactive in human cells (Stivahtis et al., 1997).
Vpr proteins from HIV-1, HIV-2, SIVsmm, and SIVmac do
induce G2 arrest both in simian and in human cells, but with
a lower efficiency for SIVmac and SIVsyk in human cells
than in simian cells (Planelles et al., 1996; Stivahtis et al.,
1997). Similarly, the data from recent reports have demon-
strated that Vpr can induce the G2 arrest of cycle in cells
from other species like in fission yeast (Masuda et al., 2000;
Barbhaiya et al., 1995; Elder et al., 2000, 2001). The fission
yeast S. pombe has been used for many years as a model to
study the mechanisms involved in the regulation of the cell
cycle. This model was also successfully used for studies of
the molecular mechanism of Vpr-induced cell cycle arrest.
Unlike these reported systems that do not mimic the real
lentiviral infection conditions, our CAEV model does and is
better equipped to decipher the biological significance of the
conservation of SIVmac Vpr and Vpx function in caprine
cells.
In our CAEV chimeric virus both SIV vpr and vpx genes
are expressed simultaneously and we were unable to distin-
guish the individual effect induced by each of these pro-
teins. The role of HIV-2/SIV Vpx protein on cell cycle
progression is less documented compared to that of HIV-1
Vpr. A couple of reports, though, have demonstrated that
Vpx from HIV-2/SIV had no effect on cell cycle arrest (Di
Marzio et al., 1995; Planelles et al., 1996). On the basis of
more recent studies which demonstrated that expression of
either HIV-2 Vpr and Vpx or SIV Vpr and Vpx resulted in
fission yeast cell arrest cycle (Zhang et al., 1997), however,
whether SIV Vpr and Vpx cooperate to induce the cell cycle
arrest remains questionable. The mechanisms which are
involved in the G2 arrest of cell cycle induced by SIVmac
Vpr are not yet well documented. In contrast, the data on the
mechanisms involved in the G2 arrest by HIV-1 Vpr dem-
onstrated a strong correlation between HIV-1 Vpr expres-
sion and a strong hyperphosphorylation of the CDC-2 ki-
nase at the inhibitory phosphorylation sites (Jowett et al.,
1995; Mahalingam et al., 1997; Barbhaiya et al., 1995;
Elder et al., 2000, 2001). The human CDC-2 kinase which
is a protein controlling the G2 phase in the cell cycle is
encoded by an highly conserved gene, with 98.7, 96, and
63% amino acid sequence homology in bovine (Yang and
Farin, 1994), murine (Spurr et al., 1990), and fission yeast
(Lee and Nurse, 1987), respectively. Recent studies have
demonstrated that HIV-1 Vpr can interact with Weel, PPA2,
and Rad24 in fission yeast and PPA2 in human and simian
cells, which are cellular factors implicated in the cell cycle
regulation (Masuda et al., 2000; Hrimech et al., 2000). On
the basis of our observations, we cannot exclude the two
hypotheses of the mechanisms that could be involved in SIV
Vpr and Vpx arrest of goat cells at the G2 phase. First, SIV
Vpr and Vpx may directly interact with the conserved cel-
lular factors like CD-C2. Second, SIV Vpr and Vpx may
interact with other goat-specific cellular factors which are
involved in the regulation of the cell cycle.
From the data here reported we cannot speculate about
the potential modification of in vivo pathogenicity of CAEV–
pBSCAvpxvpr. The role of Vpr in the pathogenesis of HIV
and SIV is still unclear. Using the SIVmac model, it was
demonstrated that the double mutant in vpr and vpx genes
does not induce disease in infected rhesus macaques, but
mutations in vpr or vpx genes separately are not sufficient to
produce nonpathogenic viruses (Gibbs et al., 1995; Hoch et
al., 1995). On the other hand the absence of disease induc-
tion in African green monkeys infected with SIVagm that
have a functional vpr gene raises the question of whether
Vpr-mediated cell cycle arrest is implicated in disease in-
duction and/or progression. Comparative experimental in-
fections of goats with CAEV–pBSCA and CAEV–pB-
SCAvpxvpr will probably bring some insight in terms of the
variation in development of the clinical signs and the se-
verity of induced pathogenesis.
The accurate elucidation of the interaction of these viral
proteins with the host cells may bring more indications that
will help to better determine the origin of these accessory
genes and their role in retrovirus evolution. This also will
help to determine the potential of emergence of new recom-
binant lentiviruses with new pathogenic properties if cross-
species transmission and virus adaptation occur.
Materials and methods
Plasmid DNA constructs
Two subcloning steps were performed to generate CAEV–
pBSCAvpxvpr chimerical genome. First, vpx and vpr genes
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were amplified by PCR from the SIVmac239 genome, using
the following primers: 5-GCT GGC CAT CCT AGA CAG
ACA AAA CTG GCA ATG GTA GCA ACA -3 and
5-GCA GCG GCC CTG AAA GTA GTA AGC GAT GTC
AGA TCC-3. These primers are complementary to se-
quences at the beginning of vpx and the end of vpr coding
sequences of SIVmac239. The 734-bp PCR product was
subcloned into the pGEM-t plasmid DNA (Promega) to
generate the pGEM–vpxvpr construct. Second, a 734-bp
fragment containing vpx and vpr coding sequences was
isolated from the pGEM–vpxvpr following double digestion
with EagI and MscI restriction enzymes. This fragment was
inserted into the unique SmaI site located at the end of tat
and upstream of env coding sequences of the genome of the
infectious molecular clone CAEV–pBSCA (Mselli-Lakhal
et al., 2000). The resulting recombinant plasmid DNA that
contained vpx and vpr genes in the orientation of CAEV
transcription was named CAEV–pBSCAvpxvpr.
Cells
GSM cells were originally obtained from explanted car-
pal synovial membrane of a colostrum-deprived newborn
goat as previously described (Narayan et al., 1980; Silva
Teixeira et al., 1997). The cells were expanded by cultiva-
tion in minimum essential medium with 10% fetal bovine
serum (Gibco–BRL, France) and then stored in liquid ni-
trogen. Typical monolayer cultures were passaged at 1:3
split ratios and used for 7–14 passages.
Transfection and virus production
CAEV–pBSCA and CAEV–pBSCAvprvpx virus stocks
were generated following transfection of 5 g of each
plasmid DNA on GSM cell monolayers seeded 24 h before
into 25-cm2 tissue culture flasks at a density of 5  105
cells, using the lipofectamine method (Silva Teixeira et al.,
1997). Eighteen hours later, the transfection medium was
removed and cell monolayers were rinsed three times with
phosphate-buffered saline (PBS). Culture supernatant was
collected on days 3, 5, and 7 posttransfection, clarified by
filtration through 0.45-m membrane pore sizes, and then
stored at 80°C for infectious virus assay.
Virus titration
Serial dilutions of CAEV–pBSCA and CAEV–pBSCA-
vprvpx were used to inoculate the indicator GSM cells
seeded the previous day into 24-well plates. Six days postin-
fection, the cell monolayers were stained with May–Gru¨n-
wald Giemsa and examined for the presence of syncytial
cytopathic effect (giant multinucleated cells). The titers
were calculated using the Reed-Muench method and ex-
pressed as the tissue culture infectious dose (TCID50) per
milliliter of supernatant.
Cytopathic effect evaluation
To quantify the cytopathic effects induced in GSM cells
infected with CAEV–pBSCA and CAEV–pBSCAvpxvpr,
105 cells/well were seeded into 6-well tissue culture plates
and 24 h later inoculated at a MOI of 0.1 with the viruses.
At 7 days postinfection cells were stained with May–Gru¨n-
wald Giemsa, and cytopathic effects represented by giant
multinucleated cells were observed by photon microscopy.
The number of nuclei per syncytium in 20 randomly se-
lected syncytia and the number of giant multinucleated cells
per field of vision in 10 randomly selected fields were
scored in infected GSM cell monolayers and used to deter-
mine the averages.
PCR analysis
PCR was used to test the stability of SIV vpx and vpr
genes inserted into CAEV–pBSCA genome. Virus CAEV–
pBSCAvpxvpr was serially passaged on GSM cultures each
7 days postinoculation by harvesting the culture medium of
infected cells and using it to inoculate fresh cells. Infected
cells from each passage were dissociated with trypsin at day
7 postinfection and then resuspended in MEM at a concen-
tration of 5  105 cells/ml. Cells were then lysed to extract
DNA for PCR analysis as recommended by the supplier
(Quiagen, DNAeasy Tissue Kit, Ref No. 69504). PCR
amplifications were performed using primers (5-GATT-
AGGGCCTGTGGATGCAG-3 and 5-CAGTTAAGC-
GCATGTATCTGG-3) specific to tat and env genes,
respectively, or (5-GCTGGCCATCCTAGACAGACA-
AAACTGGCAATGGTAGCAACA-3) and (5-GCAGCG-
GCCCTGAAAGTAGTAAGCGATGTCAGATCC-3) com-
plementary to sequences at the beginning of vpx and the end
of vpr coding sequences of SIVmac239. The tat and env
specific primers should generate a 876-bp fragment with
CAEV–pBSCAvpxvpr DNA and a 142-bp fragment with
CAEV–pBSCA DNA. The primers specific to SIV vpr and
vpx coding sequences should generate a 734-bp fragment
with CAEV–pBSCAvpxvpr DNA and no fragment with
DNA from CAEV–pBSCA. PCR amplifications were per-
formed using the following profile: denaturation at 94°C for
5 min, followed by 35 cycles of denaturation at 92°C for 1
min, annealing at 56°C for 1.5 min, and primer extension at
70°C for 3 min. After PCR amplification, 10-l aliquots
from each sample were separated by electrophoresis on
1.5% agarose gel, and then the DNA product was visualized
by staining with ethidium bromide.
Radioimmunoprecipitation of viral proteins
Immunoprecipitation of virus-specific proteins was per-
formed as previously described (Chebloune et al., 1996a).
Briefly, GSM cells were seeded at day 0 into 6-well plates
at a density of 1105 cells/well. At day 1, the monolayers
were inoculated with CAEV–pBSCA and CAEV–pBSCA-
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vprvpx at a MOI of 0.1 and incubated at 37°C in 5% CO2.
At day 7, cell monolayers were rinsed twice with serum-free
MEM and incubated for 2 h in methionine/cysteine-free
MEM and then radiolabeled overnight with 100 Ci/ml of
[35S]methionine/cysteine (Promix, Amersham, Orsay,
France) into 1 ml of the same medium. CAEV–pBSCA
specific proteins were immunoprecipitated using the hyper-
immune serum (G9615) from a goat that had received sev-
eral injections of mixture of three different CAEV and
MVV K1514 isolates. SIV Vpr/Vpx proteins were immu-
noprecipitated with an immune rabbit polyclonal antibody
directed against Vpx and Vpr proteins that we produced
following immunization of a rabbit with 1 mg of gel-puri-
fied Vpx and Vpr proteins. Immunoprecipitated proteins
were then separated by sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS–PAGE) and virus proteins
released into the culture medium and/or present in the cell
lysate fractions were visualized by standard autoradiogra-
phy.
Immunocytochemistry
GSM were seeded into eight-chamber slides (Lab-Tek).
Twenty-four hours later subconfluent cell monolayers were
inoculated with CAEV–pBSCA and CAEV–pBSCAvpxvpr
at an MOI of 0.1 and incubated at 37°C in 5% CO2. At 5
days postinoculation cells were rinsed with 1X PBS and
fixed with acetone. SIV Vpr and Vpx proteins were immu-
nocytochemically stained using the specific mouse poly-
clonal anti-SIV Vpx and Vpr antibody that we produced
following DNA immunization of mice with a construct
expressing vpx and vpr genes under CMV promoter. Cells
were first blocked with solution containing 6% of goat
serum in 1X PBS/BSA 1% and then incubated for 30 min at
37°C with the primary polyclonal antibody diluted (1/50) in
1X PBS/BSA 1%. Cell monolayers were then rinsed with
1X PBS and incubated for 30 min, with 0.5% of a biotin-
ylated rabbit anti-mouse Ig (Dako Kit, Ref No. E0432),
diluted in 1X PBS/BSA 1%. Cells were then rinsed twice
with 1X PBS and incubated for 30 min in 1X PBS solution
containing streptavidin–biotin–peroxidase complex and
then 10 min in 1X PBS solution supplemented with 1 mg/ml
diaminobenzidine. After a final rinse in water, staining was
darkened with osmic acid, and cells were then counter-
stained with hematoxylin and mounted in aqueous medium.
Appropriate negative controls were performed for the spec-
ificity of the rabbit and mouse antibodies.
Flow cytometry analysis of G2 cell cycle arrest
The quantitative measurement of cell cycle was per-
formed by flow cytometry analysis of nuclear DNA contents
following propidium iodide (Sigma, Ref No. 4170) staining
as previously described (Rogel et al., 1995). Briefly, 5105
infected cells were harvested following dissociation with
trypsin and then rinsed and resuspended into 1 ml of 1X
PBS. Cell suspensions were then fixed by the addition of 2
ml of 100% ethanol and a 30-min incubation in ice. Cells
were rinsed once with 1X PBS, incubated for 30 min at
room temperature in a solution containing RNase A (10
mg/ml), and then stained by the addition of 10 mg/ml of
propidium iodide. DNA content was finally analyzed on
over 10,000 events by FACScan flow cytometry (Becton–
Dickinson) with a 488-nm argon ion laser. For simplicity
data are presented as the G2/G1 ratio provided from Lysis II
analysis software.
To study whether the virion-imported SIV Vpr/Vpx pro-
teins are sufficient to induce G2 cell cycle arrest, 5105
GSM cells were seeded in each well of a 6-well plate and
then treated with 300 g/ml of AZT (Sigma). Two hours
later, cells were inoculated with CAEV–pBSCA and CAEV–
pBSCAvpxvpr at a MOI of 5 and kept in culture with
medium supplemented with AZT. At different times postin-
fection, the quantitative measurement of cell cycle was
performed by flow cytometry analysis following propidium
iodide staining as described above.
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